MDL-203005

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameMDL-203005
Drug Alias Nameinterleukin-1 receptors (Affymax/Hoechst Marion Roussel)IL-1 receptors (Affymax/Hoechst Marion Roussel)MDL-203005
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInterleukin-1 receptor antagonists
TargetsInterleukin-1 receptor
Therapy Area/IndicationsInflammationCardiovascular DiseasesArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAffymax NV
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAffymax NVHoechst Marion Roussel Ltd
Active IndicationsN/A
Inactive IndicationsInflammationCardiovascular DiseasesArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A